Mariusz P. Gajewski
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Professor of Chemistry
Also affiliated: University of Idaho (2001–2005); University of Montana (2007–2022)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mariusz P. Gajewski's research has focused on the design, synthesis, and biological activity of novel chemical compounds, particularly in the context of cancer treatment and neurological function. His work includes the development of triazole amino acids to investigate transport protein interactions and isoxazole derivatives with potential anticancer properties, including activity against glioblastoma cell lines. Gajewski has also investigated inhibitors of microglial glutamate release, which are relevant to neurotoxicity and neuroinflammation. His publications cover a range of chemical synthesis methodologies, including the creation of functionalized dihydropyrans and isoxazoles. Gajewski has collaborated with Steven W. Barger at the University of Arkansas for Medical Sciences on shared publications. His scholarship metrics include an h-index of 6, with 18 total publications and 113 total citations.
Metrics
- h-index: 6
- Publications: 17
- Citations: 113
Positions
-
Professor of Chemistry publications 2015–2023Arkansas Tech University Institution web page
Selected Publications
-
Design, synthesis, and characterization of novel system xC− transport inhibitors: inhibition of microglial glutamate release and neurotoxicity (2023)
-
Design, synthesis, and characterization of novel Xc- transport inhibitors: Inhibition of microglial glutamate release and neurotoxicity (2023)
-
10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line (2022)
-
AIMing towards improved antitumor efficacy (2015)
Collaboration Network
Top Collaborators
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- Design, synthesis, and characterization of novel system xC− transport inhibitors: inhibition of microglial glutamate release and neurotoxicity
- Design, synthesis, and characterization of novel Xc- transport inhibitors: Inhibition of microglial glutamate release and neurotoxicity
- AIMing towards improved antitumor efficacy
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
- 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line
Similar Researchers
Based on overlapping research topics